Participation of women in cardiovascular trials from 2017 to 2023: a systematic review

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Professor Martha Gulati

Houston Methodist DeBakey Heart & Vascular Center, Houston (United States of America)

4 More presentations in this session

Presentation thumbnail

Postmenopausal hormone therapy and major adverse cardiac events in women with prior myocardial infarction

Doctor H. Wood-Kurland (Hilleroed, DK)

Abstract Slides Video

Presentation thumbnail

Gender differences in the performance of the Chest Pain score and modified HEART score in risk stratification for cardiac events in patients presenting to the Emergency Department with chest pain

Doctor L. Pelagatti (Florence, IT)

Abstract Slides Video

Presentation thumbnail

Cardiovascular risk in autoimmune diseases: associations and interactions with traditional risk factors in a prospective population-based cohort of 450 000 individuals

Mr A. Schuermans (Leuven, BE)

Abstract Slides Video

Presentation thumbnail

Distinct risk patterns of mid-trimester systolic-diastolic blood pressure for individual and co-occurring adverse pregnancy outcomes

Miss F. Yiwen (Tianjin, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Cardiovascular health in women: from hormones to high-risk conditions

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Sex differences in effects of pharmacological treatment of heart failure: a meta-analysis and meta-regression of randomized controlled trials

Congress Presentation

Sex-based differences in access site in STEMI: the Macedonian perspective

Congress Presentation

Unlocking equity: assessing for gaps in cardiovascular guidelines for pregnant women

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources